CG Oncology (CGON) Operating Margin (2023 - 2025)
Historic Operating Margin for CG Oncology (CGON) over the last 3 years, with Q3 2025 value amounting to 3068.97%.
- CG Oncology's Operating Margin rose 627333600.0% to 3068.97% in Q3 2025 from the same period last year, while for Sep 2025 it was 8285.33%, marking a year-over-year increase of 57456700.0%. This contributed to the annual value of 10067.25% for FY2024, which is 171136300.0% up from last year.
- Per CG Oncology's latest filing, its Operating Margin stood at 3068.97% for Q3 2025, which was up 627333600.0% from 81161.54% recorded in Q1 2025.
- In the past 5 years, CG Oncology's Operating Margin ranged from a high of 3068.97% in Q3 2025 and a low of 1935500.0% during Q4 2023
- In the last 3 years, CG Oncology's Operating Margin had a median value of 23290.99% in 2024 and averaged 253606.61%.
- As far as peak fluctuations go, CG Oncology's Operating Margin surged by 2000000000bps in 2024, and later plummeted by -769140900bps in 2025.
- Quarter analysis of 3 years shows CG Oncology's Operating Margin stood at 1935500.0% in 2023, then surged by 100bps to 8344.08% in 2024, then surged by 63bps to 3068.97% in 2025.
- Its Operating Margin was 3068.97% in Q3 2025, compared to 81161.54% in Q1 2025 and 8344.08% in Q4 2024.